Development and characteriza
Tacrolimus is a potent immunosuppressant; however, it suffers from several problems such as poor water solubility (4–12 μg/mL), low and variable oral bioavailability in patients, and narrow therapeutic window that could not be solved by the currently available i.v. formulation (Prograf®). Moreover,...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer
2017-02-01
|
| Серии: | Saudi Pharmaceutical Journal |
| Предметы: | |
| Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S1319016416300676 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|